$1,673,000 cash and equivalents at the end of the quarter and $1,150,000 costs etc for the current quarter. Doesn't leave much left over. Something has to give.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025